Type 2 Diabetes (T2D) Latest Advances
Find the Latest Research About Type 2 Diabetes (T2D)
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 657272 publications
The systems medicine view of semaglutide: from clinical trials to molecular mechanisms.
Journal: Expert review of clinical pharmacology
Published: June 24, 2026
Impact of uncomplicated cataract surgery on central retinal thickness changes in diabetic patients: A short-term analysis.
Journal: The Journal of international medical research
Published: June 24, 2026
Automated Insulin Delivery Systems in Hospitals: A Systematic Review with Meta-Analysis.
Journal: Diabetes technology & therapeutics
Published: June 24, 2026
Research Progress and Application Prospects of Saliva-Based Point-of-Care Testing Technologies
Journal: Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation
Published: June 24, 2026
Staged endovascular management for non-maturing arteriovenous fistulas: A single-center retrospective cohort study.
Journal: The journal of vascular access
Published: June 24, 2026
Loneliness Among Black/African American Men With Type 2 Diabetes: Associations of Demographics, Symptomatology, and Social Networks.
Journal: The science of diabetes self-management and care
Published: June 24, 2026
Effects of sodium-glucose cotransporter 2 inhibitors on body weight and metabolic parameters in obese patients with and without type 2 diabetes: a systematized narrative review.
Journal: Current medical research and opinion
Published: June 24, 2026
Changes in persistence to basal insulin following the Medicare out-of-pocket cost cap.
Journal: The American journal of managed care
Published: June 23, 2026
A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13).
Journal: Human vaccines & immunotherapeutics
Published: June 23, 2026
Tirzepatide.
Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti
Published: June 23, 2026
Targeting GLP1R and IL17A suppresses obesity-induced leukemia in an oncogenic PTPN11 mutation-driven model.
Journal: The Journal of clinical investigation
Published: June 23, 2026
Teplizumab (Tzield) for the delay of type 1 diabetes.
Journal: JAAPA : official journal of the American Academy of Physician Assistants
Published: June 23, 2026
Last Updated: 06/30/2026